Menu
Not yet recruiting NCT05616182

Application of LARS Ligament in Bone Prosthesis Replacement

Observational Malignant Tumor

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: LARS ligament and bone prosthesis replacement was performed.
Who it may be relevant to
Registry conditions: Malignant Tumor. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Prospective, Real-world, Single-center, Cohort Study of LARS Ligaments in Bone Tumors

Overview

This is a single-center, prospective, real-world observational study designed to enroll all patients eligible for enrollment. Basic data, treatment methods, postoperative complications and limb function were collected. The differences in postoperative complications, postoperative limb function and so on between patients who underwent LARS ligament implantation and bone prosthesis replacement (ligament group) and patients who underwent bone prosthesis replacement (control group) were compared.

Detailed description

This is a single-center prospective real-world observational study of 100 eligible patients with bone tumors who are scheduled to undergo LARS ligament implantation and/or bone prosthesis replacement in Henan Cancer Hospital in the next 10 years. Basic data, treatment methods, postoperative complications and limb function were collected. The differences in postoperative complications, postoperative limb function and so on between patients who underwent LARS ligament implantation and bone prosthesis replacement (ligament group) and patients who underwent bone prosthesis replacement (control group) were compared.

Interventions

  • Other LARS ligament and bone prosthesis replacement was performed
    To report the postoperative complications and limb function of patients who underwent LARS ligament and bone prosthesis replacement in Henan Cancer Hospital.

Primary outcome measures

  • Postoperative complications [Time frame: From surgery to 24 months after surgery]
  • Limb function [Time frame: Patients were enrolled until 24 months after surgery]

Eligibility criteria

Inclusion criteria

Men and women of all ages are welcome.

Pathologically confirmed in our hospital as a subtype of malignant tumor.

He received LARS ligament and bone prosthesis replacement at our hospital.

Exclusion criteria

Not Applicable.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Other

Study locations

China · 1 center
  • Department of Bone and Soft Tissue ,Henan Cancer Hospital — Zhengzhou

Identifiers

NCT: NCT05616182 · ZZUSC-17

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗